Correlation
The correlation between LABP and CVNA is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
LABP vs. CVNA
Compare and contrast key facts about Landos Biopharma, Inc. (LABP) and Carvana Co. (CVNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LABP or CVNA.
Performance
LABP vs. CVNA - Performance Comparison
Loading data...
Key characteristics
Fundamentals
LABP:
$71.68M
CVNA:
$38.26B
LABP:
-$4.00
CVNA:
$2.88
LABP:
2.37
CVNA:
2.58
LABP:
2.11
CVNA:
29.37
Returns By Period
LABP
N/A
N/A
N/A
N/A
N/A
N/A
N/A
CVNA
60.88%
29.89%
25.63%
227.23%
123.16%
28.61%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LABP vs. CVNA — Risk-Adjusted Performance Rank
LABP
CVNA
LABP vs. CVNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Landos Biopharma, Inc. (LABP) and Carvana Co. (CVNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LABP vs. CVNA - Dividend Comparison
Neither LABP nor CVNA has paid dividends to shareholders.
Drawdowns
LABP vs. CVNA - Drawdown Comparison
Loading data...
Volatility
LABP vs. CVNA - Volatility Comparison
Loading data...
Financials
LABP vs. CVNA - Financials Comparison
This section allows you to compare key financial metrics between Landos Biopharma, Inc. and Carvana Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities